Yellow nail syndrome; Allogeneic haematopoietic cell transplantation; Graft-versus-host-disease; Multiple myeloma
Abstract :
[en] Objective and Importance: Yellow nail syndrome (YNS) is a rare disorder of unknown aetiology characterized by the triad of yellow nails, lymphoedema and respiratory manifestations. About 200 cases have been reported, but a lot of patients probably elude proper diagnosis because of both variability of symptoms and ignorance of this syndrome by many physicians. The pathogenesis remains unclear, and could involve functional lymphatic abnormalities, microvasculopathy or lymphocyte deficiency, but none of these hypotheses seems fully satisfactory.
Clinical Presentation: We report for the first time two cases of YNS associated with multiple myeloma relapsing after non-myeloablative haematopoietic cell transplantation (HCT). In these two cases, onset or worsening of YNS symptoms followed graft-versus-host disease (GvHD) manifestations.
Intervention: Corticosteroids given to treat GvHD also improved YNS manifestations.
Conclusion: YNS after HCT might be a microvascular manifestation of endothelial GvHD and corticosteroids might be an effective treatment.
Maldonado F, Tazelaar HD, Wang CW, Ryu JH. Yellow nail syndrome:analysis of 41 consecutive patients. Chest. 2008;134:375–81.10.1378/chest.08-0137
Gupta S, Samra D, Yel L, Agrawal S. T and B cell deficiency associated with yellow nail syndrome. Scand J Immunol. 2011;75:29–335.
D’Alessandro A, Muzi G, Monaco A, Filiberto S, Barboni A, Abbritti G. Yellow nail syndrome:does protein leakage play a role? Eur Respir J. 2001;17:149–52.10.1183/09031936.01.17101490
Gyger M, Rosenberg A, Shamy A, Hercz A, Caplan S, Sebag IA, et al. Vascular leak syndrome and serositis as an unusual manifestation of chronic graft-versus-host disease in nonmyeloablative transplants. Bone Marrow Transplant. 2005;35:201–203.10.1038/sj.bmt.1704730
Tichelli A, Gratwohl A. Vascular endothelium as ‘novel’ target of graft-versus-host disease [Review]. Best Pract Res Clin Haematol. 2008;21:139–48.10.1016/j.beha.2008.02.002
Penack O, Socie G, van den Brink MR. The importance of neovascularization and its inhibition for allogeneic hematopoietic stem cell transplantation. Blood. 2011;117:4181–9.10.1182/blood-2010-10-312934